CEP-6800

CAT: 0804-HY-119992Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-119992Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
CEP-6800 is an inhibitor of PARP-1 with chemopotentiating ability. CEP-6800 attenuates irinotecan (HY-16562) - and Temozolomide (HY-17364) -induced poly (ADP-ribose) accumulation in LoVo as well as HT29 xenografts. CEP-6800 can suppress Calu-6 tumor growth. CEP-6800 can be studied in anti-cancer research[1].
CAS Number
[609848-02-4]
UNSPSC
12352005
Target
PARP
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C1NC(C2=C1C3=C(C4=C2CCC4)NC5=C3C=C(CN)C=C5)=O
Molecular Formula
C18H15N3O2
Molecular Weight
305.33
References & Citations
[1]Miknyoczki, S. J., et al., (2003) . Chemopotentiation of temozolomide, irinotecan, and cisplatin activity by CEP-6800, a poly (ADP-ribose) polymerase inhibitor. Molecular cancer therapeutics, 2 (4), 371-382.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-123172CEP-2563
HY-100946-01CEP-40783
HY-14243CEP-14083
HY-117909-01CEP-40125
HY-16135-01CEP-11981
HY-15343-01CEP-33779
HY-10412CEP-1347
HY-P991435CEP-37248
HY-13590CEP-7055
HY-18030CEP-28122

Alternative Products

CatalogName
MF-0143737-01CEP-6800
8108/5CEP
2020810/CIC, 6800 CPU
M10648-01CEP-32496
MBS3844777-01CEP-40783
M10107-01CEP-28122
GW6518-5mgCEP-33779
MBS5780420CEP-1612
MBS5804885CEP-9722
TRC-P385620-10MGPseudouridine CEP

Popular Products